Switch to:

Corvus Pharmaceuticals Enterprise Value

: $55.64 Mil (As of Today)
View and export this data going back to 2016. Start your Free Trial

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Corvus Pharmaceuticals's Enterprise Value is $55.64 Mil. Corvus Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-46.99 Mil. Therefore, Corvus Pharmaceuticals's EV-to-EBIT ratio for today is -1.18.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Corvus Pharmaceuticals's Enterprise Value is $55.64 Mil. Corvus Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was $-46.28 Mil. Therefore, Corvus Pharmaceuticals's EV-to-EBITDA ratio for today is -1.20.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Corvus Pharmaceuticals's Enterprise Value is $55.64 Mil. Corvus Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00 Mil. Therefore, Corvus Pharmaceuticals's EV-to-Revenue ratio for today is .


Corvus Pharmaceuticals Enterprise Value Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corvus Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Enterprise Value Premium Member Only 0.00 164.29 127.93 -6.98 77.27

Corvus Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Enterprise Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.50 5.48 77.27 -6.75 19.76

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Corvus Pharmaceuticals Enterprise Value Distribution

* The bar in red indicates where Corvus Pharmaceuticals's Enterprise Value falls into.



Corvus Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Corvus Pharmaceuticals's Enterprise Value for the fiscal year that ended in Dec. 2019 is calculated as

Corvus Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2020 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals  (NAS:CRVS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Corvus Pharmaceuticals's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=55.642/-46.989
=-1.18

Corvus Pharmaceuticals's current Enterprise Value is $55.64 Mil.
Corvus Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was -11.513 (Sep. 2019 ) + -11.44 (Dec. 2019 ) + -13.269 (Mar. 2020 ) + -10.767 (Jun. 2020 ) = $-46.99 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Corvus Pharmaceuticals's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=55.642/-46.275
=-1.20

Corvus Pharmaceuticals's current Enterprise Value is $55.64 Mil.
Corvus Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was -11.327 (Sep. 2019 ) + -11.255 (Dec. 2019 ) + -13.085 (Mar. 2020 ) + -10.608 (Jun. 2020 ) = $-46.28 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Corvus Pharmaceuticals's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=55.642/0
=

Corvus Pharmaceuticals's current Enterprise Value is $55.64 Mil.
Corvus Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was 0 (Sep. 2019 ) + 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) = $0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Corvus Pharmaceuticals Enterprise Value Related Terms


Corvus Pharmaceuticals Enterprise Value Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)